Metraipolis › archive › dc_2d2bc7e5310b

Camel plasma as an innovative non-antibiotic therapy for Escherichia coli-induced colibacillosis in neonatal lambs: a comparative pilot study with… — Europe PMC PMID:42046668

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42046668
DOI
10.14202/vetworld.2026.1132-1148
License (as archived)
solo-consultazione
Archived
2026-11-04T07:54:03.593Z
SHA-256 of the archived text
e7a6a03c12cdb70b7f04814a8cc57d69820554788ce26ae92934d7a86de98df1
Stable URL of this page
https://metraipolis.com/documento/dc_2d2bc7e5310b

How to cite

Camel plasma as an innovative non-antibiotic therapy for Escherichia coli-induced colibacillosis in neonatal lambs: a comparative pilot study with… — Europe PMC PMID:42046668 — Europe PMC (en), https://europepmc.org/article/MED/42046668 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2d2bc7e5310b (Metraipolis archive dc_2d2bc7e5310b, sha256 e7a6a03c12cdb70b7f04814a8cc57d69820554788ce26ae92934d7a86de98df1)
BibTeX
@misc{dc2d2bc7e5310b,
  title = {Camel plasma as an innovative non-antibiotic therapy for Escherichia coli-induced colibacillosis in neonatal lambs: a comparative pilot study with… — Europe PMC PMID:42046668},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42046668},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2d2bc7e5310b; sha256 e7a6a03c12cdb70b7f04814a8cc57d69820554788ce26ae92934d7a86de98df1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42046668. Agents can read the archived copy with the MCP tool read_document.